Skip to main content Skip to Footer

ALLIANCE


Using public cloud services to accelerate business growth

With GxP solutions


MAXIMIZE THE VALUE
OF YOUR IT INVESTMENTS

Although most life sciences companies are making investments in the public cloud, it is typically in parts of the business that are subject to less regulation. Currently their public cloud spend represents a small fraction of their overall investment in IT (based on current portfolio management at top 10 pharma companies).

For any organization, public cloud computing services are likely to form a core technology component of digital transformation. The promise of near-unlimited computing; storage and networking resources at low cost; easy access to new value-added services; rapid technology innovation; and financial flexibility all combine to create a compelling value proposition for any organization looking to maximize the business value of their IT investments.

ACCENTURE’S ANALYSIS OF
MICROSOFT AZURE

Many life sciences companies are beginning their public and hybrid cloud journeys. However, when they decide to migrate GxP applications to the cloud, the infrastructure supporting it must comply with GxP requirements. Our analysis of the infrastructure underlying Microsoft Azure shows that it can be maintained in a controlled state provided proper change management and automated testing controls and management tools are in place.

Accenture’s analysis will help life sciences companies:

  • Analyze the controls required to leverage Microsoft Azure

  • Define how Microsoft Azure can meet those controls

  • Define the levels of ownership and participation from life sciences companies when validating and maintaining GxP systems hosted on Microsoft Azure

This paper is aimed at business decision makers and compliance professionals who are looking to establish the strategy for their GxP applications. As IT portfolio management is a specialized field, many organizations will find it helpful to work with a partner such as Accenture to analyze their portfolio of GxP applications, and determine which ones to move first, based on overall suitability and on the likely complexity of validation in the new environment.

DOWNLOAD THE EXECUTIVE SUMMARY [PDF]

DOWNLOAD THE FULL REPORT [PDF]

BENEFITS OF PUBLIC
CLOUD COMPUTING

In life sciences, there is a real opportunity to use public cloud services to accelerate business growth. For example:

  • Core infrastructure services can be combined with higher-level capabilities in advanced analytics and machine learning to effectively predict and improve outcomes.

  • The highly flexible application of high-performance computing capabilities allows them to be used in a much wider set of circumstances, lowering the cost of failure in research and development, and facilitating the developments of new categories of products and services.

Most life sciences companies have just scratched the surface in terms of realizing the benefits of adopting public cloud services. This is in part because most of the technology investments that yield the highest value for life sciences companies are subject to regulatory compliance considerations, and it has been unclear to date how to validate these types of applications on a public cloud platform.

GXP VALIDATION WITH
ACCENTURE + MICROSOFT AZURE

Accenture has successfully migrated thousands of GxP and non-GxP applications and databases to the cloud, while ensuring that the application is still working and maintained in a validated state. This process minimizes downtime and risk to the business by ensuring various tests (both manual and automated) are done prior to migration and post migration. This process uses qualified tools and processes to test the underlying infrastructure as well as the application.

Accenture provides validation, quality and implementation services for several top pharmaceutical and medical device companies. Their partnership with Microsoft can help assist clients as they migrate legacy systems to the Microsoft Azure platform and implement new GxP systems in the cloud.

DOWNLOAD THE EXECUTIVE SUMMARY [PDF]

DOWNLOAD THE FULL REPORT [PDF]


CONNECT WITH US

LIFE SCIENCES BLOG

Stay in touch via our Blog.

Accenture’s life sciences experts share their insights and opinions on the pharmaceutical, biotechnology, medical technology, and consumer health industries.

Read Our Blogs

LINKEDIN

Accenture’s life sciences experts share their insights and opinions on the pharmaceutical, biotechnology, medical technology, and consumer health industries.

TWITTER